Romeo y Julieta Twisted Love Story
Senators oppose application for iQOS

U.S. Senators Oppose Philip Morris International’s iQOS Application

Opposition is growing against Philip Morris International’s modified-risk application for iQOS. Ten U.S. senators–all Democrats–have sent a letter to Scott Gottlieb, the commissioner of...
Philip Morris International's Revenue and Stock Jumps Due to IQOS

Philip Morris International’s Revenue and Stock Jumps Due to IQOS

Philip Morris International (PMI) can thank the emerging market of heat-not-burn for not only meeting but beating recent revenue estimates. Earlier this year, the U.S....
FDA Grants Modified Risk Authorization to 22nd Century Group's VLN

FDA Grants Modified Risk Authorization to 22nd Century Group’s VLN

22nd Century Group, Inc., a leading agricultural biotechnology company that is focused on tobacco harm reduction and reduced nicotine tobacco products, has announced that...
PMI iQOS FDA Harm Reduction

Is the FDA on the Brink of True Harm Reduction?

In July, the FDA announced a new regulatory plan to focus on reducing nicotine levels in cigarettes, with the purpose of reducing cigarette addiction....
IQOS | Altria and Philip Morris Intrnational End U.S. Commercialization Agreement

Philip Morris International to Regain Full U.S. Commercial Rights to IQOS

Altria has reached an agreement with Philip Morris International (PMI) relating to the IQOS Tobacco Heating System. Altria has revealed that it will receive...
British American Tobacco Releases 2018 Harm Reduction Focus Report

British American Tobacco Releases 2018 Harm Reduction Focus Report

Harm reduction has been a major initiative and focus of British American Tobacco (BAT) in recent years and 2018 was no different. With the...
- Advertisement -
Premier